Life-threatening myositis after one dose of nivolumab in a patient with nonmetastatic completely resected cutaneous melanoma.

Rus, Tomaz; Gregoric Kramberger, Milica; Brecl Jakob, Gregor; Leonardis, Lea; Meznaric, Marija

Rus, Tomaz; Gregoric Kramberger, Milica; Brecl Jakob, Gregor; Leonardis, Lea; Meznaric, Marija.

Afiliação

Rus T; Department of Neurology, University Medical Centre Ljubljana, Zaloska cesta 2, 1000, Ljubljana, Slovenia.
Gregoric Kramberger M; Department of Neurology, University Medical Centre Ljubljana, Zaloska cesta 2, 1000, Ljubljana, Slovenia.
Brecl Jakob G; Department of Neurology, University Medical Centre Ljubljana, Zaloska cesta 2, 1000, Ljubljana, Slovenia.
Leonardis L; Clinical Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Zaloska cesta 7, 1000, Ljubljana, Slovenia.
Meznaric M; Faculty of Medicine, Institute of Anatomy, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia. marija.meznaric@mf.uni-lj.si.

Acta Neurol Belg ; 122(6): 1637-1639, 2022 12.

Article em En | MEDLINE | ID: mdl-34331257

Assuntos

Melanoma; Miosite; Neoplasias Cutâneas; Humanos; Nivolumabe/efeitos adversos; Melanoma/tratamento farmacológico; Melanoma/cirurgia; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/cirurgia; Miosite/induzido quimicamente; Miosite/diagnóstico por imagem; Melanoma Maligno Cutâneo

Palavras-chave

Adjuvant therapy; Adverse events; Immune checkpoint inhibitors; Nivolumab-induced myositis; Nonmetastatic melanoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma / Miosite Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google